430 related articles for article (PubMed ID: 28404155)
1. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial.
Kitano S; Inomata M; Mizusawa J; Katayama H; Watanabe M; Yamamoto S; Ito M; Saito S; Fujii S; Konishi F; Saida Y; Hasegawa H; Akagi T; Sugihara K; Yamaguchi T; Masaki T; Fukunaga Y; Murata K; Okajima M; Moriya Y; Shimada Y
Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):261-268. PubMed ID: 28404155
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
[TBL] [Abstract][Full Text] [Related]
3. Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404.
Yamamoto S; Inomata M; Katayama H; Mizusawa J; Etoh T; Konishi F; Sugihara K; Watanabe M; Moriya Y; Kitano S;
Ann Surg; 2014 Jul; 260(1):23-30. PubMed ID: 24509190
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
Katai H; Mizusawa J; Katayama H; Morita S; Yamada T; Bando E; Ito S; Takagi M; Takagane A; Teshima S; Koeda K; Nunobe S; Yoshikawa T; Terashima M; Sasako M
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):142-151. PubMed ID: 31757656
[TBL] [Abstract][Full Text] [Related]
5. Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.
Yoshikawa T; Terashima M; Mizusawa J; Nunobe S; Nishida Y; Yamada T; Kaji M; Fukushima N; Hato S; Choda Y; Yabusaki H; Yoshida K; Ito S; Takeno A; Yasuda T; Kawachi Y; Katayama H; Fukuda H; Boku N; Sano T; Sasako M
Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):208-216. PubMed ID: 30679107
[TBL] [Abstract][Full Text] [Related]
6. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
7. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L; Su X; He Z; Zhang C; Lu J; Zhang G; Sun Y; Du X; Chi P; Wang Z; Zhong M; Wu A; Zhu A; Li F; Xu J; Kang L; Suo J; Deng H; Ye Y; Ding K; Xu T; Zhang Z; Zheng M; Xiao Y;
Lancet Oncol; 2021 Mar; 22(3):391-401. PubMed ID: 33587893
[TBL] [Abstract][Full Text] [Related]
8. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
Kurokawa Y; Doki Y; Mizusawa J; Terashima M; Katai H; Yoshikawa T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Iwasaki Y; Kaji M; Hirao M; Katayama H; Sasako M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):460-468. PubMed ID: 29709558
[TBL] [Abstract][Full Text] [Related]
9. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.
; Buunen M; Veldkamp R; Hop WC; Kuhry E; Jeekel J; Haglind E; Påhlman L; Cuesta MA; Msika S; Morino M; Lacy A; Bonjer HJ
Lancet Oncol; 2009 Jan; 10(1):44-52. PubMed ID: 19071061
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses.
Shida D; Ochiai H; Tsukamoto S; Kanemitsu Y
Eur J Surg Oncol; 2018 Jul; 44(7):1025-1030. PubMed ID: 29656799
[TBL] [Abstract][Full Text] [Related]
11. Quality control by photo documentation for evaluation of laparoscopic and open colectomy with D3 resection for stage II/III colorectal cancer: Japan Clinical Oncology Group Study JCOG 0404.
Nakajima K; Inomata M; Akagi T; Etoh T; Sugihara K; Watanabe M; Yamamoto S; Katayama H; Moriya Y; Kitano S
Jpn J Clin Oncol; 2014 Sep; 44(9):799-806. PubMed ID: 25084776
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
[TBL] [Abstract][Full Text] [Related]
13. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
14. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
[TBL] [Abstract][Full Text] [Related]
15. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
Jeong SY; Park JW; Nam BH; Kim S; Kang SB; Lim SB; Choi HS; Kim DW; Chang HJ; Kim DY; Jung KH; Kim TY; Kang GH; Chie EK; Kim SY; Sohn DK; Kim DH; Kim JS; Lee HS; Kim JH; Oh JH
Lancet Oncol; 2014 Jun; 15(7):767-74. PubMed ID: 24837215
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
van der Pas MH; Haglind E; Cuesta MA; Fürst A; Lacy AM; Hop WC; Bonjer HJ;
Lancet Oncol; 2013 Mar; 14(3):210-8. PubMed ID: 23395398
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
[TBL] [Abstract][Full Text] [Related]
18. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
19. Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer.
Deijen CL; Vasmel JE; de Lange-de Klerk ESM; Cuesta MA; Coene PLO; Lange JF; Meijerink WJHJ; Jakimowicz JJ; Jeekel J; Kazemier G; Janssen IMC; Påhlman L; Haglind E; Bonjer HJ;
Surg Endosc; 2017 Jun; 31(6):2607-2615. PubMed ID: 27734203
[TBL] [Abstract][Full Text] [Related]
20. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
Liang JT; Huang KC; Lai HS; Lee PH; Sun CT
Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
